序号 |
标题 |
次数 |
作者 |
发布时间 |
69346 |
TCO PEG3 CH2CONHS,CAS: 2249928-26-3 |
72 |
WYQ |
2024-12-13 |
69347 |
Ald-CH2-PEG3-propargyl,CAS: 2249926-66-5 |
80 |
WYQ |
2024-12-13 |
69348 |
Thalidomide-O-C7-acid,2169266-70-8,沙利度胺-O-C7-酸 |
78 |
kx |
2024-12-13 |
69349 |
Ald-CH2-PEG4-propargyl,CAS: 1341156-62-4 |
81 |
WYQ |
2024-12-13 |
69350 |
Ald-benzoylamide-PEG4-CH2 NHS ester(CAS号:2709738-71-4) |
60 |
WYQ |
2024-12-13 |
69351 |
m-PEG10-C11-SH,甲基-十聚乙二醇-C11-巯基 |
58 |
kx |
2024-12-13 |
69352 |
L-Cysteine, S-[[3-(mercaptomethyl)-5-[[[2-[[2-[4,7,10-tris(carboxymethyl) |
89 |
h |
2024-12-13 |
69353 |
Ald-CH2-PEG2-Azide(CAS号:184006-13-1) |
81 |
WYQ |
2024-12-13 |
69354 |
CAS:78063-83-9,Tm-DOTA双功能螯合剂 |
72 |
h |
2024-12-13 |
69355 |
Ald-benzoylamide-PEG2-CH2 NHS ester(CAS号:2253965-05-6) |
68 |
WYQ |
2024-12-13 |
69356 |
m-PEG5-C11-SH,848589-24-2,甲基-五聚乙二醇-C11-巯基 |
61 |
kx |
2024-12-13 |
69357 |
NHS-PEG5000-C16,活性酯聚乙二醇棕榈酸 |
90 |
wyh |
2024-12-13 |
69358 |
CAS:2757339-62-9,DOTA-Tyr-Lys-DOTA |
79 |
h |
2024-12-13 |
69359 |
m-PEG3-C11-SH,594863-55-5,甲基-三聚乙二醇-C11-巯基 |
75 |
kx |
2024-12-13 |
69360 |
Cholesterol-PEG-CY5 CLS-PEG-CY5 |
75 |
wyh |
2024-12-13 |
69361 |
(DOTA-Lys(DOTA))2-Lys-Gly-Gly-Gly-N2H3*TFA |
68 |
h |
2024-12-13 |
69362 |
Pomalidomide-C10-COOH,2428400-33-1,泊马度胺-C10-酸 |
72 |
kx |
2024-12-13 |
69363 |
Ald-benzoylamide-PEG3-CH2 NHS ester,CAS: 2253965-10-3 |
78 |
WYQ |
2024-12-13 |
69364 |
[10-[2-[4-[3-[[4-[[[2-[(2S)-2-Cyano-4,4-difluoro-1-pyrrolidinyl] |
98 |
h |
2024-12-13 |
69365 |
Ald-CH2-PEG2-NHBoc,CAS: 1229024-41-2 |
55 |
WYQ |
2024-12-13 |
69366 |
NH2-PEG1000-C18 Stearic Acid, 氨基-聚乙二醇-硬脂酸 |
59 |
wyh |
2024-12-13 |
69367 |
Pomalidomide-C9-COOH,2243000-24-8,泊马度胺-C9-酸 |
71 |
kx |
2024-12-13 |
69368 |
4-Quinolinecarboxamide, N-[2-[(2S)-2-cyano-1-pyrrolidinyl]-2-oxoethyl]-6-[3-(1-piperazinyl)propoxy]- |
74 |
h |
2024-12-13 |
69369 |
Ald-CH2-PEG3-NHBoc,CAS: 2253965-06-7 |
75 |
WYQ |
2024-12-13 |
69370 |
m-PEG11-(CH2)8-Phosphonic acid,甲基-十一聚乙二醇-C8-膦酸 |
63 |
kx |
2024-12-13 |
69371 |
DOTA-五聚乙二醇-C6-二苯并环辛炔 |
62 |
h |
2024-12-13 |
69372 |
m-PEG3-(CH2)8-Phosphonic acid,2227018-98-4,甲基-三聚乙二醇-C8-膦酸 |
112 |
kx |
2024-12-13 |
69373 |
Ald-CH2-PEG4-NHBoc(CAS号2708026-80-4) |
69 |
WYQ |
2024-12-13 |
69374 |
m-PEG7-(CH2)8-Phosphonic acid,甲基-七聚乙二醇-C8-膦酸 |
73 |
kx |
2024-12-13 |
69375 |
DOTAGA-Anhydride,DOTA衍生试剂 |
76 |
h |
2024-12-13 |
69376 |
Pomalidomide-C8-NH2 hydrochloride,2446474-06-0,泊马度胺-C8-氨基盐酸盐 |
56 |
kx |
2024-12-13 |
69377 |
C18-PEG-RB ,十八烷基-聚乙二醇-罗丹明,RB-PEG-C18 |
69 |
wyh |
2024-12-13 |
69378 |
Biotin-PEG2-CH2-aldehyde(CAS号2408505-11-1) |
76 |
WYQ |
2024-12-13 |
69379 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸三(2-丙烯)酯 |
89 |
h |
2024-12-13 |
69380 |
5C18-PEG-DOPE,十八烷基-聚乙二醇-二油酰磷脂酰乙醇胺 ,DOPE-PEG-C18 |
81 |
wyh |
2024-12-13 |
69381 |
Biotin-PEG2-CH2-aldehyde(CAS号2408505-11-1) |
69 |
WYQ |
2024-12-13 |
69382 |
C16(Palmitic acid)-PEG8-Biotin ,C16(棕榈酸)-八聚乙二醇-生物素 |
78 |
kx |
2024-12-13 |
69383 |
DOTA-exendin-4,141758-74-9 |
71 |
h |
2024-12-13 |
69384 |
GADOLINATE(1-), [1,4,7,10-TETRAAZACYCLODODECANE-1,4,7,10-TETRAACETATO(4-)-KN1,KN4,KN7,KN10,KO1,KO4,KO7,KO10]- |
88 |
h |
2024-12-13 |
69385 |
DOTA-tris(t-Bu)-Amido-PEG5-Azide |
75 |
h |
2024-12-13 |
69386 |
DOTA-tris(acid)-amido-PEG24-PFP ester |
103 |
h |
2024-12-13 |
69387 |
Ald-benzoylamide-PEG2-CH2 acid,CAS号:2707975-79-7 |
68 |
WYQ |
2024-12-13 |
69388 |
DBCO-CONH-PEG4-NHCO-DBCO的组成与结构 |
79 |
kx |
2024-12-13 |
69389 |
DOTA-tris(t-Bu)-Amido-PEG4-BMPA |
111 |
h |
2024-12-13 |
69390 |
TCO-PEG4-CH2 NHS ester CAS号:2714291-24-2 |
72 |
WYQ |
2024-12-13 |